Cargando…
Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with heterogeneous aetiology and a complex genetic background. Effective therapies are therefore likely to act on convergent pathways such as dysregulated energy metabolism, linked to multiple neurodegenerative dis...
Autores principales: | Chaytow, Helena, Carroll, Emily, Gordon, David, Huang, Yu-Ting, van der Hoorn, Dinja, Smith, Hannah Louise, Becker, Thomas, Becker, Catherina Gwynne, Faller, Kiterie Maud Edwige, Talbot, Kevin, Gillingwater, Thomas Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482929/ https://www.ncbi.nlm.nih.gov/pubmed/35963713 http://dx.doi.org/10.1016/j.ebiom.2022.104202 |
Ejemplares similares
-
The role of survival motor neuron protein (SMN) in protein homeostasis
por: Chaytow, Helena, et al.
Publicado: (2018) -
Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine
por: Chaytow, Helena, et al.
Publicado: (2021) -
Automated in vivo drug screen in zebrafish identifies synapse-stabilising drugs with relevance to spinal muscular atrophy
por: Opris¸oreanu, Ana-Maria, et al.
Publicado: (2021) -
Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7
por: Huang, Yu-Ting, et al.
Publicado: (2023) -
Intraoperative floppy iris syndrome associated with terazosin
por: Venkatesh, Rengaraj, et al.
Publicado: (2007)